BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2668573)

  • 1. Group A streptococcal resistance to clindamycin and erythromycin.
    Sorbello AF
    JAMA; 1989 Sep; 262(10):1329. PubMed ID: 2668573
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.
    Cornaglia G; Ligozzi M; Mazzariol A; Valentini M; Orefici G; Fontana R
    Emerg Infect Dis; 1996; 2(4):339-42. PubMed ID: 9011381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing antibiotic resistance of streptococcus species in New York City.
    Lin K; Tierno PM; Komisar A
    Laryngoscope; 2004 Jul; 114(7):1147-50. PubMed ID: 15235338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
    Colakoglu S; Alacam R; Hascelik G
    Scand J Infect Dis; 2006; 38(6-7):456-9. PubMed ID: 16798693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance to erythromycin in strains of Streptococcus pyogenes isolated in the province of Barcelona].
    Viñado B; Domínguez J; Rodrigo C; Matas L
    Med Clin (Barc); 1999 Apr; 112(14):556. PubMed ID: 10363246
    [No Abstract]   [Full Text] [Related]  

  • 7. Leg ulcer infection with an erythromycin-resistant Streptococcus pyogenes.
    Hardie R; Hardie RA
    Scott Med J; 1986 Jan; 31(1):39. PubMed ID: 3515552
    [No Abstract]   [Full Text] [Related]  

  • 8. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
    Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group A beta-hemolytic streptococcal pharyngitis resistant to erythromycin: case report.
    Boulter MJ
    Mil Med; 1982 Jan; 147(1):62-3. PubMed ID: 6806686
    [No Abstract]   [Full Text] [Related]  

  • 10. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.
    Stevens DL; Gibbons AE; Bergstrom R; Winn V
    J Infect Dis; 1988 Jul; 158(1):23-8. PubMed ID: 3292661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic implications of erythromycin resistance in group A streptococci.
    Coonan K; Kaplan EL
    Pediatr Infect Dis J; 1993 Mar; 12(3):261-2. PubMed ID: 8451111
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of streptococcal infections: implications of antimicrobial drug resistance in Streptococcus pyogenes.
    Hansman D
    Med J Aust; 1989 Jun; 150(11):611-2. PubMed ID: 2657346
    [No Abstract]   [Full Text] [Related]  

  • 13. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
    Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens].
    Limia A; Jiménez ML; Delgado T; Sánchez I; López S; López-Brea M
    Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group A Streptococcus resistant to erythromycin and lincomycin.
    Dixon JM
    Can Med Assoc J; 1968 Dec; 99(22):1093-4. PubMed ID: 4386993
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibiotic sensitivity of Streptococcus pyogenes in pediatrics].
    Gené A; González-Cuevas A; Juncosa T; Luaces C; Latorre C
    Enferm Infecc Microbiol Clin; 1998; 16(6):272-4. PubMed ID: 9763744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance to macrolides in Streptococcus pyogenes].
    Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
    [No Abstract]   [Full Text] [Related]  

  • 18. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens.
    Melo-Cristino J; Fernandes ML
    Microb Drug Resist; 1999; 5(3):219-25. PubMed ID: 10566873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
    Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
    [No Abstract]   [Full Text] [Related]  

  • 20. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
    Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
    Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.